Hipolin shareholders approve MD re-designation at 33rd AGM
- Hipolin Limited held its 33rd AGM on September 29, 2026, via video conferencing
- Shareholders approved the re-designation of Shaileshkumar Jayantilal Shah as Executive Managing Director
- All three resolutions passed with requisite majority, including adoption of FY26 financial statements
- Voting results submitted to BSE on September 30, 2026, confirming unanimous promoter support
*this image is generated using AI for illustrative purposes only.
Hipolin Limited held its 33rd Annual General Meeting on September 29, 2026, via video conferencing. The meeting focused on adopting financial statements and approving key leadership changes.
Shareholders passed an ordinary resolution to adopt the audited financial statements for FY26, along with the Board and Auditors' reports. They also approved the re-appointment of Shaileshkumar Jayantilal Shah as a Director, who retired by rotation and offered himself for re-election.
A special resolution was passed to re-designate Mr. Shah from Non-Executive to Executive Managing Director. This change includes the approval of his remuneration package, marking a shift in the company's executive structure.
The meeting commenced at 4:08 pm and concluded at 4:35 pm. Remote e-voting facilities were available from September 25 to September 28, 2026. Only one shareholder question was received and addressed by Director Daxesh Shah during the session.
Voting results disclosed
On September 30, 2026, Hipolin submitted the consolidated voting results and scrutinizer report to BSE Ltd under Regulation 44 of SEBI (LODR) Regulations 2015. The report confirms that all three resolutions contained in the AGM notice were duly passed by members.
The total number of shareholders on the record date was 2,398. Voting participation included 10 promoters and 11 public shareholders attending through video conferencing. No shareholders attended in person or through proxy.
Resolution-wise voting breakdown
| Resolution | Type | Votes in favour | Votes against | Result |
|---|---|---|---|---|
| Adoption of Financials | Ordinary | 1,269,871 | 19,898 | Passed |
| Director Re-appointment | Ordinary | 1,269,871 | 19,898 | Passed |
| MD Re-designation | Special | 1,269,871 | 19,898 | Passed |
For all three resolutions, the promoter and promoter group voted unanimously in favour with 1,238,768 votes. Public non-institutional shareholders cast 51,001 votes, with 31,103 in favour and 19,898 against. No invalid votes were recorded for the adoption of financial statements, while 141,197 invalid votes were noted for the director re-appointment and MD re-designation resolutions within the promoter category.
Resolutions passed
| Resolution | Type | Details |
|---|---|---|
| Adoption of Financials | Ordinary | Adopted audited financial statements for FY26 |
| Director Re-appointment | Ordinary | Re-appointed Shaileshkumar Jayantilal Shah |
| MD Re-designation | Special | Re-designated Shah as Executive Managing Director |
The scrutinizer for the meeting was Megha Samdani of M/s M K Samdani & Co. The voting process was conducted via NSDL e-voting facilities.
Historical Stock Returns for Hipolin
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.11% | -0.62% | +14.17% | 0.0% | -0.99% | 0.0% |
How will Mr. Shah's transition to Executive Managing Director influence Hipolin Limited's strategic direction and operational efficiency in the upcoming fiscal year?
What specific performance benchmarks or KPIs are tied to Mr. Shah's newly approved remuneration package as Executive Managing Director?
Given that public shareholders cast nearly 39% of their votes against the MD re-designation, what measures might the board take to address minority shareholder concerns regarding governance?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
